An overview of prognostic factors in small cell lung cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1990-04

AUTHORS

NSB Rawson, J Peto,

ABSTRACT

Several studies of small cell lung cancer (SCLC) treatments have been performed in the United Kingdom. In some, prognostic factor analyses were carried out but the results were not entirely consistent. The Lung Cancer Subcommittee of the United Kingdom Coordinating Committee on Cancer Research (UKCCCR) consequently initiated an overview of these studies with the aim of identifying the important prognostic factors using a large number of patients. Information on almost 4,000 patients was available, but it was necessary to perform analyses on smaller subsets because the variables recorded in individual studies were inconsistent. A number of variables contributed significantly to the prediction of likely survival over the 6 months after starting treatment, but performance status (PS), alkaline phosphatase (AlkP) and disease stage were shown to be the most important; aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) may also be useful. A prognostic index was devised for this initial period and validated using independent data. For patients who survived the first 6 months, the pre-treatment variables important for prognosis in the 6-24 month period were stage, PS and plasma sodium (Na). The Subcommittee recommends that performance status, disease stage, AlkP, Na, AST and LDH should be measured in all future SCLC studies to assist comparisons between studies and possibly the selection of patients for different treatment strategies. The additional recording of five other variables would allow a more definitive overview to be performed at some future date. More... »

PAGES

597-604

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1990.133

DOI

http://dx.doi.org/10.1038/bjc.1990.133

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053201549

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2158808


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alkaline Phosphatase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Small Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multicenter Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rawson", 
        "givenName": "NSB", 
        "id": "sg:person.016023435447.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016023435447.13"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Peto", 
        "givenName": "J", 
        "type": "Person"
      }, 
      {}
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00257124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014635781", 
          "https://doi.org/10.1007/bf00257124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1985.197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042989161", 
          "https://doi.org/10.1038/bjc.1985.197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028460723", 
          "https://doi.org/10.1038/bjc.1989.117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00306746", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005871877", 
          "https://doi.org/10.1007/bf00306746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040634974", 
          "https://doi.org/10.1038/bjc.1989.167"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1990-04", 
    "datePublishedReg": "1990-04-01", 
    "description": "Several studies of small cell lung cancer (SCLC) treatments have been performed in the United Kingdom. In some, prognostic factor analyses were carried out but the results were not entirely consistent. The Lung Cancer Subcommittee of the United Kingdom Coordinating Committee on Cancer Research (UKCCCR) consequently initiated an overview of these studies with the aim of identifying the important prognostic factors using a large number of patients. Information on almost 4,000 patients was available, but it was necessary to perform analyses on smaller subsets because the variables recorded in individual studies were inconsistent. A number of variables contributed significantly to the prediction of likely survival over the 6 months after starting treatment, but performance status (PS), alkaline phosphatase (AlkP) and disease stage were shown to be the most important; aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) may also be useful. A prognostic index was devised for this initial period and validated using independent data. For patients who survived the first 6 months, the pre-treatment variables important for prognosis in the 6-24 month period were stage, PS and plasma sodium (Na). The Subcommittee recommends that performance status, disease stage, AlkP, Na, AST and LDH should be measured in all future SCLC studies to assist comparisons between studies and possibly the selection of patients for different treatment strategies. The additional recording of five other variables would allow a more definitive overview to be performed at some future date.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.1990.133", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "61"
      }
    ], 
    "keywords": [
      "performance status", 
      "aspartate aminotransferase", 
      "prognostic factors", 
      "disease stage", 
      "small cell lung cancer treatment", 
      "United Kingdom Coordinating Committee", 
      "small cell lung cancer", 
      "cell lung cancer treatment", 
      "prognostic factor analysis", 
      "important prognostic factor", 
      "selection of patients", 
      "cell lung cancer", 
      "pre-treatment variables", 
      "different treatment strategies", 
      "lung cancer treatment", 
      "prognostic index", 
      "lung cancer", 
      "treatment strategies", 
      "plasma sodium", 
      "patients", 
      "cancer treatment", 
      "individual studies", 
      "month period", 
      "alkaline phosphatase", 
      "cancer research", 
      "months", 
      "additional recordings", 
      "treatment", 
      "status", 
      "prognosis", 
      "study", 
      "cancer", 
      "small subset", 
      "aminotransferase", 
      "Coordinating Committee", 
      "initial period", 
      "period", 
      "AlkP", 
      "survival", 
      "factors", 
      "United Kingdom", 
      "Subcommittee", 
      "stage", 
      "definitive overview", 
      "factor analysis", 
      "aim", 
      "recordings", 
      "variables", 
      "LDH", 
      "likely survival", 
      "sodium", 
      "subset", 
      "index", 
      "phosphatase", 
      "dehydrogenase", 
      "number", 
      "Committee", 
      "date", 
      "large number", 
      "overview", 
      "analysis", 
      "data", 
      "strategies", 
      "Na", 
      "comparison", 
      "results", 
      "Kingdom", 
      "number of variables", 
      "information", 
      "research", 
      "selection", 
      "future date", 
      "independent data", 
      "prediction", 
      "Lung Cancer Subcommittee", 
      "Cancer Subcommittee", 
      "Kingdom Coordinating Committee", 
      "future SCLC studies", 
      "SCLC studies"
    ], 
    "name": "An overview of prognostic factors in small cell lung cancer", 
    "pagination": "597-604", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053201549"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1990.133"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2158808"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1990.133", 
      "https://app.dimensions.ai/details/publication/pub.1053201549"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_222.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.1990.133"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1990.133'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1990.133'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1990.133'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1990.133'


 

This table displays all metadata directly associated to this object as RDF triples.

228 TRIPLES      22 PREDICATES      126 URIs      113 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1990.133 schema:about N14b5a75e812140dfba110eb3f4dfb920
2 N172f6c76466d43b1abbca83a4224a6ad
3 N24ca15952d8e4ca0a076778cc1ca9466
4 N2c33d53f6f934342bbc1a6db922757d7
5 N4b8b913f5f7145458ff020867d50a246
6 N4fe634a990974c35ba7605de97816a3e
7 N539f4b58dee04d7e96e9b66829f28462
8 N5845fc2faa7f4bc8a33209d329f44ae5
9 N5c3b4f54434f4fd49ed180750996afca
10 N93e60062925c4c41a545cae3274562be
11 N9cdfac1c879d466d9328f2712e88ce74
12 Ndc447077a61c44bb83586ef7fa23159d
13 Ne5d3e71e9c4d4031b00f3e0c2d37c580
14 Neadc1dd0ada5420fa11d0e518a77038f
15 Nfdb5cd253dd7458d9e66c884fa67b0c9
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author Nfbf6245c685c4bb1b41979f7316b3b59
19 schema:citation sg:pub.10.1007/bf00257124
20 sg:pub.10.1007/bf00306746
21 sg:pub.10.1038/bjc.1985.197
22 sg:pub.10.1038/bjc.1989.117
23 sg:pub.10.1038/bjc.1989.167
24 schema:datePublished 1990-04
25 schema:datePublishedReg 1990-04-01
26 schema:description Several studies of small cell lung cancer (SCLC) treatments have been performed in the United Kingdom. In some, prognostic factor analyses were carried out but the results were not entirely consistent. The Lung Cancer Subcommittee of the United Kingdom Coordinating Committee on Cancer Research (UKCCCR) consequently initiated an overview of these studies with the aim of identifying the important prognostic factors using a large number of patients. Information on almost 4,000 patients was available, but it was necessary to perform analyses on smaller subsets because the variables recorded in individual studies were inconsistent. A number of variables contributed significantly to the prediction of likely survival over the 6 months after starting treatment, but performance status (PS), alkaline phosphatase (AlkP) and disease stage were shown to be the most important; aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) may also be useful. A prognostic index was devised for this initial period and validated using independent data. For patients who survived the first 6 months, the pre-treatment variables important for prognosis in the 6-24 month period were stage, PS and plasma sodium (Na). The Subcommittee recommends that performance status, disease stage, AlkP, Na, AST and LDH should be measured in all future SCLC studies to assist comparisons between studies and possibly the selection of patients for different treatment strategies. The additional recording of five other variables would allow a more definitive overview to be performed at some future date.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N32ac3bf3cad445beab35a02db371c7ce
31 Ne2b49902ad224dc1be9b29809f1d7565
32 sg:journal.1017082
33 schema:keywords AlkP
34 Cancer Subcommittee
35 Committee
36 Coordinating Committee
37 Kingdom
38 Kingdom Coordinating Committee
39 LDH
40 Lung Cancer Subcommittee
41 Na
42 SCLC studies
43 Subcommittee
44 United Kingdom
45 United Kingdom Coordinating Committee
46 additional recordings
47 aim
48 alkaline phosphatase
49 aminotransferase
50 analysis
51 aspartate aminotransferase
52 cancer
53 cancer research
54 cancer treatment
55 cell lung cancer
56 cell lung cancer treatment
57 comparison
58 data
59 date
60 definitive overview
61 dehydrogenase
62 different treatment strategies
63 disease stage
64 factor analysis
65 factors
66 future SCLC studies
67 future date
68 important prognostic factor
69 independent data
70 index
71 individual studies
72 information
73 initial period
74 large number
75 likely survival
76 lung cancer
77 lung cancer treatment
78 month period
79 months
80 number
81 number of variables
82 overview
83 patients
84 performance status
85 period
86 phosphatase
87 plasma sodium
88 pre-treatment variables
89 prediction
90 prognosis
91 prognostic factor analysis
92 prognostic factors
93 prognostic index
94 recordings
95 research
96 results
97 selection
98 selection of patients
99 small cell lung cancer
100 small cell lung cancer treatment
101 small subset
102 sodium
103 stage
104 status
105 strategies
106 study
107 subset
108 survival
109 treatment
110 treatment strategies
111 variables
112 schema:name An overview of prognostic factors in small cell lung cancer
113 schema:pagination 597-604
114 schema:productId N50c873baa481453893bcf375b06df280
115 N698fbbc904ed426baee8ab9764c75c57
116 Nda9e4fa1834d4123a9cee52420fb19d2
117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053201549
118 https://doi.org/10.1038/bjc.1990.133
119 schema:sdDatePublished 2021-12-01T19:06
120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
121 schema:sdPublisher N9773fd478305484c8894fe91bd962c45
122 schema:url https://doi.org/10.1038/bjc.1990.133
123 sgo:license sg:explorer/license/
124 sgo:sdDataset articles
125 rdf:type schema:ScholarlyArticle
126 N14b5a75e812140dfba110eb3f4dfb920 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Aged
128 rdf:type schema:DefinedTerm
129 N172f6c76466d43b1abbca83a4224a6ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Lung Neoplasms
131 rdf:type schema:DefinedTerm
132 N24ca15952d8e4ca0a076778cc1ca9466 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Humans
134 rdf:type schema:DefinedTerm
135 N2c33d53f6f934342bbc1a6db922757d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Multicenter Studies as Topic
137 rdf:type schema:DefinedTerm
138 N32ac3bf3cad445beab35a02db371c7ce schema:volumeNumber 61
139 rdf:type schema:PublicationVolume
140 N432e48ea48a949109e01126af10679d5 schema:familyName Peto
141 schema:givenName J
142 rdf:type schema:Person
143 N4b8b913f5f7145458ff020867d50a246 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Sodium
145 rdf:type schema:DefinedTerm
146 N4c911fb8dff844669fccae000f337553 rdf:first N432e48ea48a949109e01126af10679d5
147 rdf:rest N92a187af7faf4b368b6457769fcfd15b
148 N4fe634a990974c35ba7605de97816a3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name United Kingdom
150 rdf:type schema:DefinedTerm
151 N50c873baa481453893bcf375b06df280 schema:name doi
152 schema:value 10.1038/bjc.1990.133
153 rdf:type schema:PropertyValue
154 N539f4b58dee04d7e96e9b66829f28462 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Alkaline Phosphatase
156 rdf:type schema:DefinedTerm
157 N5845fc2faa7f4bc8a33209d329f44ae5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Carcinoma, Small Cell
159 rdf:type schema:DefinedTerm
160 N5c3b4f54434f4fd49ed180750996afca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Prognosis
162 rdf:type schema:DefinedTerm
163 N698fbbc904ed426baee8ab9764c75c57 schema:name pubmed_id
164 schema:value 2158808
165 rdf:type schema:PropertyValue
166 N92a187af7faf4b368b6457769fcfd15b rdf:first N994b9677daf14d25a8729e0b4d6b94ed
167 rdf:rest rdf:nil
168 N93e60062925c4c41a545cae3274562be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Female
170 rdf:type schema:DefinedTerm
171 N9773fd478305484c8894fe91bd962c45 schema:name Springer Nature - SN SciGraph project
172 rdf:type schema:Organization
173 N9cdfac1c879d466d9328f2712e88ce74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Neoplasm Staging
175 rdf:type schema:DefinedTerm
176 Nda9e4fa1834d4123a9cee52420fb19d2 schema:name dimensions_id
177 schema:value pub.1053201549
178 rdf:type schema:PropertyValue
179 Ndc447077a61c44bb83586ef7fa23159d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Aged, 80 and over
181 rdf:type schema:DefinedTerm
182 Ne2b49902ad224dc1be9b29809f1d7565 schema:issueNumber 4
183 rdf:type schema:PublicationIssue
184 Ne5d3e71e9c4d4031b00f3e0c2d37c580 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Adult
186 rdf:type schema:DefinedTerm
187 Neadc1dd0ada5420fa11d0e518a77038f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Middle Aged
189 rdf:type schema:DefinedTerm
190 Nfbf6245c685c4bb1b41979f7316b3b59 rdf:first sg:person.016023435447.13
191 rdf:rest N4c911fb8dff844669fccae000f337553
192 Nfdb5cd253dd7458d9e66c884fa67b0c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Male
194 rdf:type schema:DefinedTerm
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
199 schema:name Oncology and Carcinogenesis
200 rdf:type schema:DefinedTerm
201 sg:journal.1017082 schema:issn 0007-0920
202 1532-1827
203 schema:name British Journal of Cancer
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.016023435447.13 schema:affiliation grid-institutes:grid.18886.3f
207 schema:familyName Rawson
208 schema:givenName NSB
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016023435447.13
210 rdf:type schema:Person
211 sg:pub.10.1007/bf00257124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014635781
212 https://doi.org/10.1007/bf00257124
213 rdf:type schema:CreativeWork
214 sg:pub.10.1007/bf00306746 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005871877
215 https://doi.org/10.1007/bf00306746
216 rdf:type schema:CreativeWork
217 sg:pub.10.1038/bjc.1985.197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042989161
218 https://doi.org/10.1038/bjc.1985.197
219 rdf:type schema:CreativeWork
220 sg:pub.10.1038/bjc.1989.117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028460723
221 https://doi.org/10.1038/bjc.1989.117
222 rdf:type schema:CreativeWork
223 sg:pub.10.1038/bjc.1989.167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040634974
224 https://doi.org/10.1038/bjc.1989.167
225 rdf:type schema:CreativeWork
226 grid-institutes:grid.18886.3f schema:alternateName Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK
227 schema:name Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK
228 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...